MINI FUTURE SHORT - JOHNSON & JOHNSON Share Price

Certificat

I3RKB

NLBNPNL29WI6

Market Closed - Euronext Paris 10:00:02 21/05/2024 pm IST
4.431 EUR +2.57% Intraday chart for MINI FUTURE SHORT - JOHNSON & JOHNSON
Current month-13.25%
1 month-11.29%
Date Price Change
21/24/21 4.431 +2.57%
20/24/20 4.32 +1.84%
17/24/17 4.242 -1.81%
16/24/16 4.32 -3.03%
15/24/15 4.455 -2.77%

Real-time Euronext Paris

Last update May 21, 2024 at 10:00 pm IST

More quotes

Static data

Product typeKnock-Out con Stop Loss
Buy / SellPUT
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer BNP Paribas BNP Paribas
I3RKB
ISINNLBNPNL29WI6
Date issued 17/02/2023
Strike 199.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.73
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.325
Lowest since issue 2.25

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.2 USD
Average target price
173.3 USD
Spread / Average Target
+14.56%
Consensus
  1. Stock Market
  2. Certificates
  3. I3RKB Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW